Aberdeen Asset Management’s Core Laboratories CLB Stock Holding History

Aberdeen Asset Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$628K	Sell	6,200 -70,732	-92%	-$7.63M	﹤0.01%	705
2017 Q1	$8.89M	Sell	76,932 -1,074	-1%	-$125K	0.03%	361
2016 Q4	$9.36M	Sell	78,006 -1,847	-2%	-$205K	0.04%	333
2016 Q3	$8.97M	Buy	79,853 +21,814	+38%	+$2.51M	0.03%	338
2016 Q2	$7.19M	Sell	58,039 -9,999	-15%	-$1.21M	0.03%	363
2016 Q1	$7.65M	Buy	68,038 +17,838	+36%	+$1.85M	0.03%	340
2015 Q4	$5.55M	Buy	+50,200	New	+$5.75M	0.02%	404
2015 Q3	–	Sell	-26,473	Closed	-$3.02M	–	688
2015 Q2	$3.02M	Sell	26,473 -678	-2%	-$82.2K	0.01%	465
2015 Q1	$2.84M	Buy	27,151 +690	+3%	+$73.5K	0.01%	485
2014 Q4	$3.18M	Sell	26,461 -14,492	-35%	-$1.9M	0.01%	462
2014 Q3	$5.99M	Sell	40,953 -11,722	-22%	-$1.81M	0.01%	389
2014 Q2	$8.8M	Buy	+52,675	New	+$9.37M	0.02%	345

Other funds holding CLB

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Aberdeen Asset Management's CLB Position: Q2 2017 in Review

Aberdeen Asset Management reduced its Core Laboratories (CLB) stake by 92% in Q2 2017, selling an estimated $7.63M and leaving 6,200 shares worth $628K. The position accounts for ﹤0.01% of the portfolio, ranked #705.

Aberdeen Asset Management first reported a position in CLB in Q2 2014 and has held it in 12 quarters since. The position peaked at $9.36M in Q4 2016. 360 funds tracked by Wall St. Rank hold CLB as of Q2 2017.

Aberdeen Asset Management held 6,200 shares of Core Laboratories worth $628K as of Q2 2017.
Aberdeen Asset Management sold 70,732 Core Laboratories shares in Q2 2017, an estimated $7.63M.
Core Laboratories made up ﹤0.01% of Aberdeen Asset Management's portfolio in Q2 2017, its #705 holding.
Aberdeen Asset Management first reported a position in Core Laboratories in Q2 2014 and has held it in 12 quarters since.
Aberdeen Asset Management's Core Laboratories position peaked at $9.36M in Q4 2016.
360 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2017.

Based on Aberdeen Asset Management's 13F filing for Q2 2017, filed 10 Aug 2017.